HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.

AbstractCONTEXT:
Anorexia nervosa (AN), a state of chronic nutritional deprivation, is characterized by GH resistance with elevated GH levels and decreased levels of IGF-I. Fibroblast growth factor (FGF)-21, a hormone produced in the liver and adipocytes, is induced in the liver by fasting and peroxisome proliferator-activated receptor-alpha agonists. In a transgenic mouse model, FGF-21 reduces IGF-I levels by inhibiting signal transducer and activator of transcription-5, a mediator of the intracellular effects of GH.
OBJECTIVE:
The objective of the study was to investigate the relationship between FGF-21, GH, and IGF-I in AN.
DESIGN:
This was a cross-sectional study.
SETTING:
The study was conducted at a clinical research center.
PATIENTS:
Patients included 23 girls: 11 with AN (16.5 +/- 0.6 yr) and 12 normal-weight controls (15.7 +/- 0.5 yr).
INTERVENTIONS:
There were no interventions.
MAIN OUTCOME MEASURES:
We measured fasting FGF-21, glucose, insulin, IGF-I, and total area under the curve for GH (GH-AUC) and leptin during 12-h overnight frequent sampling.
RESULTS:
FGF-21 levels were significantly higher in AN compared with controls, and there was a positive correlation between FGF-21 and GH-AUC (P = 0.03) after controlling for percent body fat and insulin resistance. In subjects with elevated FGF-21 levels, there was a strong inverse association between FGF-21 and IGF-I (R = -0.88, P = 0.004). FGF-21 strongly correlated with total area under the curve for leptin (R = 0.67, P = 0.02).
CONCLUSIONS:
FGF-21 levels are higher in AN independent of the effects of percent body fat and insulin resistance. The positive association between FGF-21 and GH-AUC and the inverse association between elevated FGF-21 levels and IGF-I suggests that above the normal range, FGF-21 may mediate a state of GH resistance in AN.
AuthorsPouneh K Fazeli, Madhusmita Misra, Mark Goldstein, Karen K Miller, Anne Klibanski
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 95 Issue 1 Pg. 369-74 (Jan 2010) ISSN: 1945-7197 [Electronic] United States
PMID19926712 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Blood Glucose
  • Insulin
  • Leptin
  • fibroblast growth factor 21
  • Human Growth Hormone
  • Fibroblast Growth Factors
  • Insulin-Like Growth Factor I
Topics
  • Adolescent
  • Anorexia Nervosa (blood, diagnosis, metabolism)
  • Area Under Curve
  • Blood Glucose (analysis)
  • Body Composition (physiology)
  • Case-Control Studies
  • Drug Resistance (physiology)
  • Female
  • Fibroblast Growth Factors (blood, physiology)
  • Health
  • Human Growth Hormone (blood, physiology)
  • Humans
  • Insulin (blood)
  • Insulin-Like Growth Factor I (analysis)
  • Leptin (blood)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: